Strategy | Financing Transactions Private Placement / Financing Transactions AltruBio: The company raised an estimated $225 million of Series B venture funding in a deal led by BVF Partners on May 21, 2024. Soleus Capital, Blackstone, aMoon Fund, RA Capital...
Strategy | Financing Transactions Private Placement / Financing Transactions Lycia Therapeutics: The company raised $106.6 million of Series C venture funding in a deal led by Venrock on May 13, 2024, putting the company’s pre-money valuation at $213.4 million....
Strategy | Financing Transactions Private Placement / Financing Transactions Zenas: The company raised $200 million of Series C venture funding in a deal led by Delos Capital, SR One Capital Management and New Enterprise Associates on May 7, 2024. Fairmount Funds...
Strategy | Financing Transactions Private Placement / Financing Transactions Innovaccer: The company raised $250 million in Series F venture funding from Kaiser Permanente, Mubadala Capital and other undisclosed investors on April 30, 2024, putting the company’s...
Strategy | Financing Transactions Private Placement / Financing Transactions Cerevance: The company raised $163 million of Series B venture funding in a deal led by Agent Capital, Bioluminescence Ventures and Double Point Ventures on April 25, 2024. GV, Takeda...
Strategy | Financing Transactions Private Placement / Financing Transactions TORL BioTherapeutics: The company raised $158.3 million of Series B venture funding in a deal led by Deep Track Capital on April 10, 2024. Bristol-Myers Squibb, Perceptive Xontogeny Venture...
